Controlled release of microquantities of macromolecules

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Polymer Chemistry

Background:

• Controlled release of macromolecules is crucial for targeted therapies.
• Existing polymeric systems face challenges in delivering small quantities of active compounds.
• Growth factors, often needed in microgram amounts, require precise delivery mechanisms.

Purpose of the Study:

• To develop a technique for controlled release of small amounts of macromolecules from polymeric systems.
• To assess the efficacy of albumin incorporation for sustained macromolecule delivery.
• To evaluate the biocompatibility of albumin-modified polymers in vivo.

Main Methods:

• Incorporation of albumin (milligram quantities) into polymeric delivery systems.
• Utilizing inulin as a model macromolecule to study release kinetics.
• Assessing polymer biocompatibility using the chick chorioallantoic membrane (CAM) and rabbit cornea models.

Main Results:

• Albumin incorporation facilitated sustained release of nanogram/microgram quantities of inulin.
• Albumin-containing polymers showed no inflammation or tissue damage in CAM and cornea assays.
• The method is suitable for delivering small, active amounts of purified growth factors.

Conclusions:

• A novel, safe, and effective method for controlled macromolecule release using albumin has been developed.
• This technique is particularly promising for the delivery of potent, low-dose biological agents like growth factors.
• The biocompatibility of these albumin-modified polymers supports their potential therapeutic applications.